ARTICLE | Clinical News
Besifloxacin ophthalmic solution regulatory update
October 27, 2008 7:00 AM UTC
FDA's Dermatologic and Ophthalmic Drugs Advisory Committee will meet on Dec. 5 to discuss an NDA from Bausch & Lomb for besifloxacin ophthalmic solution to treat bacterial conjunctivitis. Besifloxacin...